Program

PRELIMINARY PROGRAM

	Day 1 - Wednesday, 28 October
	9:00	Opening of the Meeting
	9:05	Andrea De Luca Lecture: The Top 10 Important Observations of the Last Year Affecting Clinical Management Jade Ghosn, MD, PhD - Bichat University Hospital, France

	Session 1: Challenges in Central and Eastern Europe
	9:35	Epidemiology of HIV and Hepatitis in CEE Teymur Noori - European Centre for Disease Prevention and Control (ECDC), Sweden
	10:00	Transmitted and Acquired Resistance: Special Populations Anca Streinu - Cercel, MD, PhD - National Institute of Infectious Diseases "Prof. Dr. Matei Bals", Romania
	10:25	HIV and Tuberculosis in CEE Speaker to be announced
	10:50	Scaling-Up Integration of TB, HIV, and Viral Hepatitis Testing in Europe Speaker to be announced
	11:15	Discussion

	11:30	Coffee Break

	Industry-Sponsored Symposium
	12:00	Symposium

	13:00	Lunch

	Session 2: Patient-Reported Outcomes and Studies
	14:00	Introductory Lecture Martin Duracinsky, MD, PhD - Paris Diderot University, France
	14:25	Discussion

	Abstract-Driven Presentations
	14:50	4 slots

	15:50	Coffee Break

	Session 3: Clinical Management of HIV: Abstract-Driven Presentations
	16:20	When to Start: Test and Treat Speaker to be announced
	16:45	Clinical Case Romain Palich, MD - Pitié - Salpêtrière Hospital, France

	17:10	Best of Posters
	17:30	Guided Poster Tour 1

		Welcome Reception and Poster Viewing

	Day 2 - Thursday, 29 October
	Session 4: What's in the Pipeline? Presentations from Scientists in the Industry
	8:30	Kathleen Squires, MD Global Director Scientific Affairs - ID/HIV, Merck, USA
	8:45	Hanneke Schuitemaker, PhD Vice President, Head Viral Vaccine Discovery and Translational Medicine, Janssen, The Netherlands
	9:00	Kirsten White, MD, PhD Senior Director, Clinical Virology, Gilead Sciences, USA
	9:15	Michael Aboud, MBChB Global Franchise Medical Head, ViiV Healthcare, UK
	9:30	Antoine Deslandes, PharmD, PhD Scientific Advisor - Translational Medicine and Early Development, Sanofi, France

	9:45	Discussion

	10:15	Coffee Break and Poster Viewing
		Guided Poster Tour 2

	Industry-Sponsored Symposium
	11:15	Symposium

	12:15	Lunch

	Session 5: Resistance to Long-Acting Antivirals
	13:15	Resistance to Long-Acting Antivirals Anne-Geneviève Marcelin, PharmD, PhD - Sorbonne Université, France
	13:45	Pro-Con Debate: Long-Acting Therapy is for Patients with Poor/Good Adherence Charles Flexner, MD - Johns Hopkins University School of Medicine, USA

	Abstract-Driven Presentations
	14:15	3 slots

	15:00	Coffee Break

	Session 6: Management of Viral Hepatitis
	15:30	Treatment of Hepatitis B for HIV Clinicians Anna Maria Geretti, MD, PhD - University of Liverpool, UK
	16:00	Hepatitis C Resistance: Pro-Con Debate
		JM Pawlotsky, MD, PhD - University of Paris-Est, France
		Francesca Ceccherini - Silberstein, PhD - University of Rome “Tor Vergata”, Italy
	16:30	Re-Infection and Retreatment: Challenges and Approaches Karine Lacombe, MD, PhD - Hôpital Saint Antoine Paris, France

	Abstract-Driven Presentations
	17:00	2 slots

	17:30	Guided Poster Tour 3
	18:00	End of Program Day 2

	19:00	Group Dinner in Le Train Bleu Restaurant (pre-registration required)
	Day 3 - Friday, 30 October
	Session 7: PrEP and Resistance
	8:30	Overview Lecture Constance Delaugerre, MD - Hopital Saint Louis, France
	9:00	Round Table Discussion: Challenges to Widespread PrEP in Europe
		Clinical Aspects Milosz Parczewski, MD, PhD - Pomeranian Medical University, Poland
		Social Aspects Michael Meulbroek - BCN Checkpoint, Spain
		Financial Aspects Yazdan Yazdanpanah, MD, PhD - Bichat Claude-Bernard Hospital, France

	Abstract-Driven Presentations
	10:00	2 slots

	10:30	Coffee Break

	Session 8: Vaccine Development / Immune Modulation
	11:00	Clinical Trials on Vaccines / Vaccine as Prevention and Vaccine as Treatment Beatriz Mothe Pujadas, MD - IrsiCaixa Foundation, Spain
	11:30	TLR Agonists Ole Søgaard, MD, PhD - Aarhus University Hospital, Denmark
	12:00	bnABs Olivier Schwartz, PhD - Institut Pasteur, France
	12:30	Reservoirs and DNA sequencing Mathias Lichterfeld, MD, PhD - Harvard University Center for AIDS Research, USA

	13:00	Closure of the Workshop and Ricardo Camacho Awards

Event date

Event address

Important dates

Registration deadlines

Abstract submission

PRELIMINARY PROGRAM

Day 1 - Wednesday, 28 October

Day 2 - Thursday, 29 October

Day 3 - Friday, 30 October